No actionable bearish signal from this cluster. CEO selling at ~0.006% market cap is routine diversification. Monitor the next quarterly filing (Form 4/10-Q) for any acceleration or broadening of C-suite sales volume, but no near-term catalyst is implied. The broad equity grants on June 2 suggest normal compensation cycles, not distress.
Price Chart
Executive Summary
CEO Daniel Carestio and Director Richard Breeden sold a combined $966K in open-market STE shares over a 5-day window (May 28–June 4), while a separate cluster filing shows Carestio also sold an additional $291K on June 5. Tax-withholding and equity-grant transactions by multiple executives (Burton, Fraser, Kohler, Zangerle, Madsen, Tamaro, Boulud) are non-cash events with no economic signal. The open-market sales total ~0.005% of STE's $20.7B market cap — well below the 0.1% threshold for materiality — and CEO selling is not accompanied by broad C-suite or director selling (only 2 insiders). Per academic literature, insider sales clusters have weak predictive power, particularly at this trivial size relative to market cap, and the calibration data shows prior neutral/mixed calls on STE have underperformed at T+20 (avg alpha -5.76%). The sales are likely routine diversification rather than an informed negative signal.
Key Financial Metrics
Key Facts
- CEO Daniel Carestio sold $947K open-market (June 4-5, $212-$215 range), plus $291K on June 5 per separate filing
- Director Richard Breeden sold $310K open-market on June 2 at $209.51
- Total open-market cash-out: ~$1.26M across 3 insiders; ~0.006% of $20.7B market cap
- Multiple executives (CFO, SVP, etc.) had non-cash tax-withholding and equity-grant transactions — no economic signal
- Prior STE calls averaged T+20 alpha of -5.76% vs SPY (n=3 settled, 33% win rate)
Financial Impact
Total open-market sales of ~$1.26M against $20.7B market cap; no material economic impact or change in ownership structure
Risk Factors
- CEO continued selling in subsequent periods could signal waning conviction; watch next 10-Q for revenue/earnings trajectory
- Sector headwinds in surgical supplies/margin pressure could emerge without insider trading as a leading indicator
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-STE-1780950733972 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 9w ago | Press Release | $230.34 $236.44 | ▲ +2.65% | ▼ −0.73% | $208.54 (−9.46%) |
Jun 15, 2026 15w ago | 144 | $206.51 $208.73 | ▲ +1.07% | ▲ +0.88% | $208.54 (+0.98%) |
Jun 11, 2026 16w ago | DEFA14A | $207.56 $216.00 | ▲ +4.07% | ▲ +2.29% | $208.54 (+0.47%) |
Jun 8, 2026 16w ago | Insider Cluster | $212.88 $215.39 | ▲ +1.18% | ▼ −0.27% | $208.54 (−2.04%) |
Jun 5, 2026 17w ago | 144 | $210.03 $213.28 | ▲ +1.55% | ▼ −0.08% | $208.54 (−0.71%) |
Jun 4, 2026 17w ago | 144 | $212.35 $213.28 | ▲ +0.44% | ▼ −1.42% | $208.54 (−1.79%) |
May 11, 2026 20w ago | 8-K | $210.23 $208.10 | ▲ +1.01% | ▼ −0.71% | $208.54 (+0.80%) |
May 11, 2026 20w ago | Press Release | $210.23 $208.10 | ▼ −1.01% | ▲ +0.71% | $208.54 (−0.80%) |
May 7, 2026 21w ago | 8-K | $207.24 $212.35 | ▲ +2.47% | ▲ +2.44% | $208.54 (+0.63%) |
Apr 21, 2026 23w ago | Press Release | $222.61 $214.42 | ▼ −3.68% | ▼ −6.84% | $208.54 (−6.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access